Impact of 2.0g Daily of MAG-EPA on the AA/EPA Ratio and Inflammation Biomarkers in a Healthy Population Aged of 50+.
Clinical trial NCT04897893 · COMPLETED
Trial details
- NCT number
- NCT04897893
- Sponsor
- SCF Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2023-04-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.